• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌的临床病理特征作为预后不良的预测指标

Clinicopathological Features as Prognostic Predictors of Poor Outcome in Papillary Thyroid Carcinoma.

作者信息

Póvoa Antónia Afonso, Teixeira Elisabete, Bella-Cueto Maria Rosa, Melo Miguel, Oliveira Maria João, Sobrinho-Simões Manuel, Maciel Jorge, Soares Paula

机构信息

Department of General Surgery, Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E), 4434-502 Gaia, Portugal.

IPATIMUP-Instituto de Patologia e Imunologia Molecular, Universidade do Porto, 4200-135 Porto, Portugal.

出版信息

Cancers (Basel). 2020 Oct 29;12(11):3186. doi: 10.3390/cancers12113186.

DOI:10.3390/cancers12113186
PMID:33138175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7693726/
Abstract

Papillary thyroid cancer (PTC) has an indolent nature and usually excellent prognosis. Some PTC clinicopathological features may contribute to the development of aggressive metastatic disease. In this work, we want to evaluate PTC clinicopathological features that are presurgical prognostic predictors of patients' outcomes and find which indicators are more adequate for tailoring surgical procedures and follow-up. We studied a series of 241 PTC patients submitted to surgery. All patients' files and histological tumor samples were reviewed. The 8th edition AJCC/UICC (American Joint Committee on Cancer/Union for International Cancer) Controlstaging system and the 2015 American Thyroid Association risk stratification system were used. Total thyroidectomy was performed in 228 patients, lymphadenectomy in 28 patients. Gross extrathyroidal extension (ETE) was present in 10 patients and 31 tumor resection margins were incomplete. Cervical lymph node metastases (LNMs) were present in 34 patients and distant metastases at diagnosis in four patients. In multivariate analysis, male gender (OR = 15.4, = 0.015), venous invasion (OR = 16.7, = 0.022), and lateral compartment LNM (OR = 26.7, = 0.004) were predictors of mortality; psammoma bodies (PBs) (OR = 4.5, = 0.008), lymph vessel invasion (OR = 6.9, < 0.001), and gross ETE (OR = 16.1, = 0.001) were predictors of structural disease status; male gender (OR = 2.9, = 0.011), lymph vessel invasion (OR = 2.8, = 0.006), and incomplete resection margins (OR = 4.6, < 0.001) were predictors of recurrent/persistent disease. Our study supports that the factors helping to tailor patient's surgery are male gender, presence of PBs, gross ETE, and lateral compartment LNM. Together with pathological factors, lymph vessel invasion, venous invasion, necrosis, and incomplete surgical resection, should be taken into consideration regarding treatment and follow-up of patients.

摘要

甲状腺乳头状癌(PTC)具有惰性本质,通常预后良好。一些PTC的临床病理特征可能促使侵袭性转移性疾病的发生。在本研究中,我们旨在评估PTC的临床病理特征,这些特征是患者预后的术前预测指标,并找出哪些指标更适合用于指导手术操作和随访。我们研究了241例行手术治疗的PTC患者。回顾了所有患者的病历和肿瘤组织样本。采用美国癌症联合委员会/国际癌症联盟(AJCC/UICC)第8版分期系统和2015年美国甲状腺协会风险分层系统。228例患者行甲状腺全切除术,28例患者行淋巴结清扫术。10例患者存在肉眼可见的甲状腺外侵犯(ETE),31例患者肿瘤切除切缘不完整。34例患者存在颈部淋巴结转移(LNM),4例患者诊断时存在远处转移。多因素分析显示,男性(OR = 15.4,P = 0.015)、血管侵犯(OR = 16.7,P = 0.022)和侧方区LNM(OR = 26.7,P = 0.004)是死亡的预测因素;砂粒体(PBs)(OR = 4.5,P = 0.008)、淋巴管侵犯(OR = 6.9,P < 0.001)和肉眼可见的ETE(OR = 16.1,P = 0.001)是结构疾病状态的预测因素;男性(OR = 2.9,P = 0.011)、淋巴管侵犯(OR = 2.8,P = 0.006)和切缘不完整(OR = 4.6,P < 0.001)是复发/持续性疾病的预测因素。我们的研究支持,有助于指导患者手术的因素包括男性、PBs的存在、肉眼可见的ETE和侧方区LNM。在考虑患者的治疗和随访时,应将淋巴管侵犯、血管侵犯、坏死和手术切除不完整等病理因素一并考虑在内。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107a/7693726/2dc54dce2142/cancers-12-03186-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107a/7693726/a8e4e27181f5/cancers-12-03186-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107a/7693726/5dfe0971324c/cancers-12-03186-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107a/7693726/2dc54dce2142/cancers-12-03186-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107a/7693726/a8e4e27181f5/cancers-12-03186-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107a/7693726/5dfe0971324c/cancers-12-03186-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107a/7693726/2dc54dce2142/cancers-12-03186-g003.jpg

相似文献

1
Clinicopathological Features as Prognostic Predictors of Poor Outcome in Papillary Thyroid Carcinoma.甲状腺乳头状癌的临床病理特征作为预后不良的预测指标
Cancers (Basel). 2020 Oct 29;12(11):3186. doi: 10.3390/cancers12113186.
2
Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.儿童和青少年甲状腺乳头状癌中央区和侧方区颈部淋巴结转移的预测因素
World J Surg. 2018 Aug;42(8):2444-2453. doi: 10.1007/s00268-018-4487-z.
3
Microscopic Extrathyroidal Extension Results in Increased Rate of Tumor Recurrence and Is an Independent Predictor of Patient's Outcome in Middle Eastern Papillary Thyroid Carcinoma.显微镜下甲状腺外侵犯导致肿瘤复发率增加,是中东地区乳头状甲状腺癌患者预后的独立预测因素。
Front Oncol. 2021 Dec 1;11:724432. doi: 10.3389/fonc.2021.724432. eCollection 2021.
4
Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.预测甲状腺乳头状癌中央区淋巴结和侧颈区淋巴结转移的因素。
Clin Transl Oncol. 2019 Nov;21(11):1482-1491. doi: 10.1007/s12094-019-02076-0. Epub 2019 Mar 16.
5
The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems.在甲状腺乳头状癌中,淋巴结转移或甲状腺外侵犯的二元存在或不存在与生存无关:对分期系统的影响。
Cancer Epidemiol. 2019 Dec;63:101589. doi: 10.1016/j.canep.2019.101589. Epub 2019 Sep 5.
6
Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.经腋后(TARA)入路机器人辅助施行 Sistrunk 手术、甲状腺全切除术和颈淋巴结清扫术治疗甲状舌管囊肿和甲状腺起源的乳头状癌
Ann Surg Oncol. 2012 Dec;19(13):4259-61. doi: 10.1245/s10434-012-2674-y. Epub 2012 Oct 16.
7
An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.评估影响甲状腺乳头状癌中央区和侧区淋巴结转移的临床病理因素
J Natl Med Assoc. 2018 Aug;110(4):384-390. doi: 10.1016/j.jnma.2017.07.007. Epub 2017 Aug 7.
8
Ultrasonographic Features, Nodule Size, Capsular Invasion, and Lymph Node Metastasis of Solitary Papillary Carcinoma of Thyroid Isthmus.甲状腺峡部孤立性乳头状癌的超声特征、结节大小、包膜侵犯及淋巴结转移
Front Oncol. 2020 Sep 29;10:558363. doi: 10.3389/fonc.2020.558363. eCollection 2020.
9
Clinical implications of microscopic extrathyroidal extension in patients with papillary thyroid carcinoma.甲状腺乳头状癌患者显微镜下甲状腺外侵犯的临床意义。
Oral Oncol. 2017 Sep;72:183-187. doi: 10.1016/j.oraloncology.2017.02.008. Epub 2017 Feb 20.
10
Persistent and recurrent disease in patients with papillary thyroid carcinoma with clinically apparent (cN1), but not extensive, lymph node involvement and without other factors for poor prognosis.乳头状甲状腺癌患者存在持续性和复发性疾病,伴有临床明显(cN1)但不广泛的淋巴结受累,且无其他预后不良因素。
Arch Endocrinol Metab. 2015 Aug;59(4):285-91. doi: 10.1590/2359-3997000000081.

引用本文的文献

1
Analysis of Risk Factors for High-Risk Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌高危淋巴结转移的危险因素分析
Cancers (Basel). 2025 Aug 6;17(15):2585. doi: 10.3390/cancers17152585.
2
A risk stratification model based on ultrasound radiologic features for cervical metastatic lymph nodes in papillary thyroid cancer.基于超声影像学特征的甲状腺乳头状癌颈部转移淋巴结风险分层模型
World J Surg Oncol. 2025 Mar 25;23(1):102. doi: 10.1186/s12957-025-03722-4.
3
Internal jugular vein tumor thrombus in papillary thyroid cancer: our institution's experience and a systematic review of the literature.

本文引用的文献

1
Molecular Aspects of Thyroid Calcification.甲状腺钙化的分子方面。
Int J Mol Sci. 2020 Oct 19;21(20):7718. doi: 10.3390/ijms21207718.
2
Data set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting.甲状腺癌报告数据集:国际癌症报告合作组织的建议。
Hum Pathol. 2021 Apr;110:62-72. doi: 10.1016/j.humpath.2020.08.009. Epub 2020 Sep 10.
3
Cancer statistics, 2020.癌症统计数据,2020 年。
甲状腺乳头状癌颈内静脉瘤栓:我们机构的经验及文献系统综述
Front Endocrinol (Lausanne). 2025 Feb 25;16:1514455. doi: 10.3389/fendo.2025.1514455. eCollection 2025.
4
Disparities in Thyroid Cancer Mortality Across Racial and Ethnic Groups: Assessing the Impact of Socioeconomic, Clinicopathologic, and Treatment Variations.不同种族和族裔群体甲状腺癌死亡率的差异:评估社会经济、临床病理和治疗差异的影响。
Ann Surg Oncol. 2025 Feb;32(2):1158-1175. doi: 10.1245/s10434-024-16569-y. Epub 2024 Nov 29.
5
Long-term efficacy of lobectomy for stage T1 papillary thyroid carcinoma with varying degrees of lymph node metastasis.不同程度淋巴结转移的 T1 期甲状腺乳头状癌行 lobectomy 的长期疗效。
Front Endocrinol (Lausanne). 2024 Aug 8;15:1453601. doi: 10.3389/fendo.2024.1453601. eCollection 2024.
6
Predictors of response to Radioactive Iodine Therapy in Intermediate and high risk patients with papillary thyroid carcinoma.预测中高危甲状腺乳头状癌患者放射性碘治疗反应的因素。
BMC Endocr Disord. 2024 Jul 15;24(1):112. doi: 10.1186/s12902-024-01648-8.
7
A Cuproptosis-Related gene Signature as a Prognostic Biomarker in Thyroid Cancer Based on Transcriptomics.基于转录组学的铜死亡相关基因特征作为甲状腺癌的预后生物标志物
Biochem Genet. 2025 Apr;63(2):1584-1604. doi: 10.1007/s10528-024-10767-9. Epub 2024 Apr 9.
8
Incidental thyroid carcinoma in an endemic goiter area in Italy: histopathological features and predictors of a common finding.意大利地方性甲状腺肿地区偶发甲状腺癌:常见发现的组织病理学特征和预测因素。
Endocrine. 2024 May;84(2):589-597. doi: 10.1007/s12020-023-03659-2. Epub 2024 Jan 13.
9
Prevalence of Differentiated High-Grade Thyroid Carcinoma Among Well-Differentiated Tumors: A Systematic Review and Meta-Analysis.分化型高级别甲状腺癌在分化型肿瘤中的患病率:一项系统评价和荟萃分析
Thyroid. 2024 Mar;34(3):314-323. doi: 10.1089/thy.2023.0350.
10
Impact of V600E Mutation on Event-Free Survival in Patients with Papillary Thyroid Carcinoma: A Retrospective Study in a Romanian Population.V600E突变对甲状腺乳头状癌患者无事件生存期的影响:罗马尼亚人群的回顾性研究
Cancers (Basel). 2023 Aug 11;15(16):4053. doi: 10.3390/cancers15164053.
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
4
Critical Prognostic Parameters in the Anatomic Pathology Reporting of Differentiated Follicular Cell-Derived Thyroid Carcinoma.分化型滤泡细胞源性甲状腺癌解剖病理学报告中的关键预后参数
Cancers (Basel). 2019 Aug 2;11(8):1100. doi: 10.3390/cancers11081100.
5
Cell and Molecular Biology of Thyroid Disorders.甲状腺疾病的细胞与分子生物学。
Int J Mol Sci. 2019 Jun 13;20(12):2895. doi: 10.3390/ijms20122895.
6
Incidental thyroid papillary microcarcinoma: survival and follow-up.偶发性甲状腺微小乳头状癌:生存情况及随访
Laryngoscope. 2019 Jul;129(7):1722-1726. doi: 10.1002/lary.27664. Epub 2019 Jan 7.
7
Multifocality related factors in papillary thyroid carcinoma.甲状腺乳头状癌多灶性相关因素。
Asian J Surg. 2019 Jan;42(1):297-302. doi: 10.1016/j.asjsur.2018.05.004. Epub 2018 Jul 4.
8
Relationship between ultrasonographic and pathologic calcification patterns in papillary thyroid cancer.甲状腺乳头状癌超声与病理钙化模式之间的关系。
Medicine (Baltimore). 2018 Oct;97(41):e12675. doi: 10.1097/MD.0000000000012675.
9
OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines.OPNa 过表达与甲状腺癌细胞系中的基质钙化有关。
Int J Mol Sci. 2018 Sep 30;19(10):2990. doi: 10.3390/ijms19102990.
10
Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.接受常规预防性中央区淋巴结清扫术的cN0M0期乳头状甲状腺癌患者中央区淋巴结无复发生存率预后良好。
World J Surg. 2018 Aug;42(8):2462-2468. doi: 10.1007/s00268-018-4497-x.